A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

NCT03978689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer
HPV Positive Oropharyngeal Squamous Cell Carcinoma
HPV-Related Carcinoma

Interventions

DRUG: CUE-101
DRUG: KEYTRUDA®, Pembrolizumab

Sponsor

Cue Biopharma

Collaborators

[object Object]